Zhejiang Wolwo Bio-Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 9.91%

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) has an Asset Resilience Ratio of 9.91% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥286.82 Million

≈ $41.97 Million USD Cash + Short-term Investments

Total Assets

CN¥2.89 Billion

≈ $423.37 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See 300357 net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300357 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥286.82 Million	9.91%
Total Liquid Assets	CN¥286.82 Million	9.91%

Asset Resilience Insights

Limited Liquidity: Zhejiang Wolwo Bio-Pharmaceutical Co Ltd maintains only 9.91% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	7.18%
CSPC Pharmaceutical Group Limited F:CVG	Drug Manufacturers - General	4.64%
Aurora Optoelectronics Co Ltd SHG:600666	Drug Manufacturers - General	5.89%
Shandong Keyuan Pharmaceutical Co. Ltd. A SHE:301281	Drug Manufacturers - General	6.44%
Dimed S.A. Distribuidora de Medicamentos SA:PNVL3	Drug Manufacturers - General	10.10%
Pfizer Inc NYSE:PFE	Drug Manufacturers - General	7.18%
Merck & Company Inc NYSE:MRK	Drug Manufacturers - General	14.06%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%

Annual Asset Resilience Ratio for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (2014–2024)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	7.24%	CN¥196.09 Million ≈ $28.69 Million	CN¥2.71 Billion ≈ $396.43 Million	+2.66pp
2023-12-31	4.58%	CN¥117.39 Million ≈ $17.18 Million	CN¥2.56 Billion ≈ $374.93 Million	-8.84pp
2022-12-31	13.42%	CN¥295.05 Million ≈ $43.18 Million	CN¥2.20 Billion ≈ $321.62 Million	-5.78pp
2021-12-31	19.20%	CN¥370.93 Million ≈ $54.28 Million	CN¥1.93 Billion ≈ $282.71 Million	+0.07pp
2020-12-31	19.13%	CN¥307.03 Million ≈ $44.93 Million	CN¥1.60 Billion ≈ $234.83 Million	+16.24pp
2019-12-31	2.90%	CN¥41.37 Million ≈ $6.05 Million	CN¥1.43 Billion ≈ $208.99 Million	-8.07pp
2018-12-31	10.97%	CN¥116.00 Million ≈ $16.97 Million	CN¥1.06 Billion ≈ $154.80 Million	-24.40pp
2017-12-31	35.36%	CN¥300.00 Million ≈ $43.90 Million	CN¥848.31 Million ≈ $124.13 Million	+10.83pp
2016-12-31	24.54%	CN¥171.00 Million ≈ $25.02 Million	CN¥696.89 Million ≈ $101.98 Million	+8.18pp
2015-12-31	16.35%	CN¥100.00 Million ≈ $14.63 Million	CN¥611.49 Million ≈ $89.48 Million	+5.06pp
2014-12-31	11.29%	CN¥60.00 Million ≈ $8.78 Million	CN¥531.31 Million ≈ $77.75 Million	--

pp = percentage points

About Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

SHE:300357 China Drug Manufacturers - General

Market Cap

$1.95 Billion

CN¥13.30 Billion CNY

Market Cap Rank

#6380 Global

#1424 in China

Share Price

CN¥25.40

Change (1 day)

-1.82%

52-Week Range

CN¥19.38 - CN¥35.30

All Time High

CN¥5101.55